0001209191-17-037922.txt : 20170605
0001209191-17-037922.hdr.sgml : 20170605
20170605180513
ACCESSION NUMBER: 0001209191-17-037922
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170601
FILED AS OF DATE: 20170605
DATE AS OF CHANGE: 20170605
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH IAN F
CENTRAL INDEX KEY: 0001197032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 17892473
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS, INC.
STREET 2: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-01
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197032
SMITH IAN F
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, CFO & COO
Common Stock
2017-06-01
4
M
0
37383
45.11
A
163621
D
Common Stock
2017-06-01
4
M
0
18124
48.74
A
181745
D
Common Stock
2017-06-01
4
M
0
23789
37.86
A
205534
D
Common Stock
2017-06-01
4
M
0
9062
51.75
A
214596
D
Common Stock
2017-06-01
4
M
0
10195
38.80
A
224791
D
Common Stock
2017-06-01
4
S
0
98553
124.00
D
126238
D
Common Stock
5306
I
401(k)
Stock Option (Right to Buy)
45.11
2017-06-01
4
M
0
37383
0.00
D
2023-02-04
Common Stock
37383
0
D
Stock Option (Right to Buy)
48.74
2017-06-01
4
M
0
18124
0.00
D
2022-07-24
Common Stock
18124
0
D
Stock Option (Right to Buy)
37.86
2017-06-01
4
M
0
23789
0.00
D
2022-02-01
Common Stock
23789
0
D
Stock Option (Right to Buy)
51.75
2017-06-01
4
M
0
9062
0.00
D
2021-07-12
Common Stock
9062
0
D
Stock Option (Right to Buy)
38.80
2017-06-01
4
M
0
10195
0.00
D
2021-02-02
Common Stock
10195
0
D
Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.
Fully vested.
Omar White, Attorney-In-Fact
2017-06-05